Literature DB >> 22974778

The 7th Edition of the TNM staging system for lung cancer: what the radiologist needs to know.

Constantine A Raptis1, Sanjeev Bhalla.   

Abstract

Today lung cancer remains the leading cause of cancer-related death in the United States, accounting for 28% of all cases. Radiologists play an important role in the assessment of this large number of patients. Given the important role imaging plays in the care of patients with lung cancer, it is incumbent on the radiologist to have a firm understanding of the TNM (tumor-node-metastasis) staging system used to describe the distribution of disease in lung cancer. This article reviews the 7th Edition of the TNM staging system for lung cancer and important changes from the 6th Edition.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22974778     DOI: 10.1016/j.rcl.2012.06.001

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  3 in total

Review 1.  Cardiothoracic manifestations of neuroendocrine tumours.

Authors:  Ramin Mandegaran; Sarojini David; Nicholas Screaton
Journal:  Br J Radiol       Date:  2016-01-19       Impact factor: 3.039

2.  Invasive adenocarcinoma of the lung is associated with the upper lung regions.

Authors:  C Matthew Kinsey; Raul San Jose Estepar; Yang Zhao; Xiaojin Yu; Nancy Diao; Rebecca Suk Heist; John C Wain; Eugene J Mark; George Washko; David C Christiani
Journal:  Lung Cancer       Date:  2014-02-11       Impact factor: 5.705

3.  External validation of the eighth edition of the TNM classification for lung cancer in 3,611 surgically treated patients at a single institution.

Authors:  Jia Wang; Nan Wu; Chao Lv; Yue Yang
Journal:  Ann Transl Med       Date:  2020-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.